FDA Recommends Postponing Abbott MitraClip Approval
U.S. Food and Drug Administration staff on Monday recommended against giving the green light to Abbott Laboratories' implantable heart device MitraClip, saying the product lacks safety and efficacy data support....To view the full article, register now.
Already a subscriber? Click here to view full article